Alphagalileo > Item Display
St. Jude Children’s Research Hospital phase II clinical trial results suggest that the monoclonal antibody hu14.18K322A could help change treatment of....
Source: alphagalileo.org
German Based Merck News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from German Based Merck. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In German Based Merck Today - Breaking & Trending Today
Novel monoclonal antibody could help revolutionize treatment of children with high-risk neuroblastoma
Survival rates increased about 20% for children with high-risk neuroblastoma enrolled in a St. Jude Children’s Research Hospital clinical trial that included a novel monoclonal antibody produced onsite. The findings appeared today in the Journal of Clinical Oncology.
Source: news-medical.net
Chemoimmunotherapy dramatically improved survival of high-risk neuroblastoma patients
Wayne Furman, MD, of the Department of Oncology Solid Tumor Division, is the first and corresponding author of the paper pubished in the Journal of
Source: miragenews.com